<DOC>
	<DOC>NCT00637182</DOC>
	<brief_summary>The purpose of this study is to look at the effect of anastrozole (ZD1033, Arimidexâ„¢) in reducing gynecomastia in pubertal boys treated with placebo in Trial 1033US/0006 (another anastrozole study).</brief_summary>
	<brief_title>Gynecomastia Extension Study</brief_title>
	<detailed_description />
	<mesh_term>Gynecomastia</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Subjects must have entered Trial 1033US/0006 and completed 6 months of treatment and one month of followup. Subjects must have gynecomastia, with one breast measuring at least 3 cm in diameter. Subjects who have been given medications known to cause gynecomastia within the previous 3 months</criteria>
	<gender>Male</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Gynecomastia</keyword>
	<keyword>Anastrazole</keyword>
	<keyword>Arimidex</keyword>
	<keyword>Pubertal</keyword>
	<keyword>males</keyword>
	<keyword>boys</keyword>
</DOC>